iRhythm Technologies

650 Townsend Street, Suite 380

San Francisco

California

94103

United States

(415) 632-5700

(415) 632-5701

[email protected]

http://www.irhythmtech.com

Related Content

CE mark reinforces the Zio monitor system as a leading innovation in ambulatory cardiac monitoring and highlights the company’s commitment to providing the highest quality product and services globally

News | Wearables

iRhythm Technologies Receives European Union’s CE Marking Under Medical Device Regulation (EU MDR) for its Zio monitor and ZEUS System

January 3, 2024 — iRhythm Technologies, Inc., a leading digital health care company focused on creating trusted ...

January 03, 2024

Rhythm is launching its next generation long-term ambulatory cardiac monitor in the U.S.

News | Wearables

iRhythm Launches Next Generation Zio Monitor and Enhanced Zio Service

September 27, 2023 — iRhythm Technologies, Inc. announced the U.S. launch of its next-generation Zio monitor and ...

September 27, 2023

Clinical studies presented at Heart Rhythm 2023 build on the totality of clinical evidence that continue to highlight the value of iRhythm’s Zio products and services across a wide range of patient populations

News | ECG

New Data From iRhythm Reinforce the Utility of Long-Term Ambulatory Cardiac Monitoring for Increased Diagnostic Yield and Improved Diagnostic Accuracy of Actionable Arrhythmias

May 24, 2023 — Rhythm Technologies, Inc., a leading digital health care company focused on creating trusted solutions ...

May 24, 2023

News | Atrial Fibrillation

Zio by iRhythm Shown to Prevent Hospital Admissions, Aid in Early Detection of AF

April 12, 2022 – iRhythm Technologies, Inc., a leading digital healthcare solutions company focused on the advancement ...

April 12, 2022

iRhythm Technologies, Inc., a leading digital healthcare solutions company focused on the advancement of cardiac care, announced that the results of the KP-Rhythm2 study, titled “Diagnostic yield, outcomes and resource utilization with different ambulatory electrocardiographic monitoring strategies,” were published in the American Journal of Cardiology (AJC).

News | Atrial Fibrillation

Zio by iRhythm Shows Significantly Higher Documentation of Atrial Fibrillation and Atrial Flutter Compared to Holter Monitors, Event Monitors

February 28, 2022 – iRhythm Technologies, Inc., a leading digital healthcare solutions company focused on the ...

February 28, 2022

iRhythm Technologies Inc. announced two new U.S. Food and Drug Administration (FDA) 510(k) clearances — one for a new and improved design of its flagship Zio wearable cardiac monitor, and a second for updated artificial intelligence (AI) capabilities.

News | Wearables

FDA Clears Smaller iRhythm Monitor with AI Arrhythmia Detection

May 25, 2021 — iRhythm Technologies Inc. announced two new U.S. Food and Drug Administration (FDA) 510(k) clearances — ...

May 25, 2021

The three-year clinical outcomes of the mHealth Screening to Prevent Strokes (mSToPS) study evaluated the detection of silent, or previously undiagnosed, atrial fibrillation (AF) in moderate-risk individuals using the FDA-cleared Zio by iRhythm ambulatory monitoring patch. The results support the clinical value of early screening and targeted detection in moderate-risk populations. #AHA #AHA20 #AHA2020

News | Atrial Fibrillation

Wearable Heart Monitor Detects Previously Undiagnosed Atrial Fibrillation to Prevent Hospitalizations, Stroke and Death

November 16, 2020 — The three-year clinical outcomes of the mHealth Screening to Prevent Strokes (mSToPS) study ...

November 16, 2020

News | ECG Monitoring Services

RHYTHM Study Reveals Link Between Total AF Burden and Stroke Risk

May 17, 2018 — A new study published in JAMA Cardiology used the Zio continuous cardiac monitoring system by iRhythm to ...

May 17, 2018

News | Wearables

Self-Applied Chest Patch Catches Atrial Fibrillation More Quickly Than Usual Care

March 19, 2018 — For people at heightened risk for atrial fibrillation (AFib), a common heart rhythm disorder that also ...

March 19, 2018

News | Artificial Intelligence

iRhythm and Stanford Researchers Develop Deep Learning-Based Cardiac Arrhthymia Detection Algorithm

July 11, 2017 — iRhythm Technologies Inc. announced a collaboration with the Stanford Machine Learning Group that has ...

July 11, 2017